FAP and non-small cell lung carcinoma: In the aforementioned meta-analysis, one study on 59 patients with NSCLC was included by Liao et al. They performed immunohistochemical staining with anti-FAP antibodies on specimens of resected tumors, and assessed the percentage of both staining and intensity.